Co-lyophilised blend of GHK-Cu, BPC-157 and TB-500. For in-vitro laboratory research use only.
£59.99
Out of stock
Triple GIP, GLP-1 and glucagon receptor agonist. Lyophilised powder for in-vitro metabolic research.
order within —
On all UK orders — discreet and tracked.
We ship across the EU & internationally, tracked to your door.
Orders placed before 12pm GMT ship the same day from our UK hub.
Lost or damaged? We reship — no questions. Order with confidence.
Analytical data
Specifications for this compound, independently verified by HPLC and LC-MS before release.
| Property | GLP-3 (RT) |
|---|---|
| Full name | Retatrutide (LY3437943) |
| CAS number | 2381089-83-2 |
| Molecular formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molecular weight | 4731.33 g/mol |
| Purity (HPLC) | ≥ 99.0% (RP-HPLC) |
| Mass confirmation | Confirmed by LC-MS |
| Residual moisture | ≤ 5.0% (Karl Fischer) |
| Form | Lyophilised powder |
| Solubility | Bacteriostatic or sterile water |
| Storage | −20°C sealed and protected from light; 2–8°C once reconstituted |
| Half-life | Approximately 6 days, per published pharmacokinetic studies |
About this peptide
Retatrutide is supplied as a laboratory research material for qualified analytical and in-vitro research environments.
01 Single-chain peptide
39 amino acids carrying a C20 fatty-diacid moiety, molecular weight 4731.33 g/mol.
02 Triple receptor agonist
Activity at the GIP, GLP-1 and glucagon receptors — the first molecule of its class to reach late-stage trials.
03 Published record
Phase 2 data in The New England Journal of Medicine and The Lancet, 2023; first-in-human pharmacology in Nature Metabolism, 2022.
04 Research material
Supplied lyophilised at −20°C with a batch certificate of analysis, for analytical and in-vitro use only.
Single-chain peptide 01
39 amino acids carrying a C20 fatty-diacid moiety, molecular weight 4731.33 g/mol.
Triple receptor agonist 02
Activity at the GIP, GLP-1 and glucagon receptors — the first molecule of its class to reach late-stage trials.
03 Published record
Phase 2 data in The New England Journal of Medicine and The Lancet, 2023; first-in-human pharmacology in Nature Metabolism, 2022.
04 Research material
Supplied lyophilised at −20°C with a batch certificate of analysis, for analytical and in-vitro use only.
FAQ
Anything not covered here, ask us directly — replies within one working day.
More from the catalogue
Co-lyophilised blend of GHK-Cu, BPC-157 and TB-500. For in-vitro laboratory research use only.
£59.99
Out of stock
Synthetic peptide fragment of thymosin beta-4. Supplied lyophilised for cell-based research.
£35.99
Out of stock
Stable pentadecapeptide derived from gastric protein. For in-vitro laboratory research use only.
£22.99
Bacteriostatic water needed?
Your vials ship freeze-dried. Add water for reconstitution if you need it.